Illumina

Illumina adds European headquarters in Cambridge, England

Friday, June 26, 2015 09:23 AM

Illumina, a San Diego-based provider of sequencing and array-based technologies, has signed a 20-year lease for a 155,000 square foot new and innovative scientific research building in Cambridge, England. The project will provide Illumina a collaborative environment and access to the highly skilled workforce in the dynamic research cluster anchored by Cambridge University.

More... »


Denali Therapeutics launches to study neurodegenerative disease treatments

Friday, May 15, 2015 02:23 PM

Denali Therapeutics, a new California-based biotechnology company focused on developing effective therapies for neurodegenerative diseases, has launched with an initial investment commitment of $217 million. Denali is based on the collaboration of world-class scientists, industry experts and investors. Recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines for Alzheimer's disease, Parkinson's disease, ALS and other neurodegenerative diseases.

More... »


Illumina, Merck Serono collaborate to expand companion diagnostics for oncology

Wednesday, March 11, 2015 12:22 PM

Illumina, a San Diego-based provider of sequencing and array-based technologies, has formed a collaboration with Merck Serono, the biopharmaceuticals business of Merck, based in Darmstadt, Germany, to develop a universal next-generation sequencing (NGS)-based oncology diagnostic.

More... »

WuXi PharmaTech acquires NextCODE Health

Friday, January 9, 2015 01:58 PM

WuXi PharmaTech, an open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries with operations in China and the U.S., has acquired NextCODE Health, a genomic analysis and bioinformatics company with operations in the U.S. and Iceland, for $65 million in cash.

More... »

USAID, Broad Institute, Illumina partner in West Africa for Ebola

Wednesday, November 19, 2014 02:22 PM

To help combat the Ebola epidemic in West Africa, the U.S. Agency for International Development (USAID), the Massachusetts-based Broad Institute of MIT and Harvard and San Diego, Calif.-based Illumina have entered into a public-private partnership.

More... »

Ab Sciex, Illumina collaborate to create multi-omics cloud-computing environment

Monday, October 6, 2014 03:43 PM

Ab Sciex, a Framingham, Mass.-based global provider of mass spectrometry products, and San Diego, Calif.-based Illumina, a global provider of sequencing and array-based technologies, have announced the OneOmics project, an exclusive partnership to bring together SWATH-based next-generation proteomics (NGP) and next-generation sequencing (NGS) tools in a cloud computing environment.

More... »

Expression Analysis, Illumina launch 2014 grant program

Monday, August 25, 2014 02:13 PM

Expression Analysis (EA), a Quintiles company based in Research Triangle Park, N.C., is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research.

More... »

Illumina partners with AstraZeneca, Janssen, Sanofi for oncology

Thursday, August 21, 2014 01:42 PM

Illumina, a California-based developer, manufacturer and marketer of life science tools and integrated systems for the analysis of genetic variation and function, has formed collaborative partnerships with AstraZenecaJanssen Biotech and Sanofi to develop a universal next-generation sequencing (NGS)-based oncology test system.

More... »

NIH awards $14.5M to research groups studying DNA sequencing techniques

Tuesday, August 5, 2014 09:00 AM

A number of micro-sized technologies—such as nanopores and microfluidics—are among the approaches researchers will use to develop high-quality, low-cost DNA sequencing technology through new grants from the NIH. The grants, which total approximately $14.5 million to eight research teams over two to four years as funds become available, are the last to be awarded by the Advanced DNA Sequencing Technology program of the National Human Genome Research Institute (NHGRI), a part of NIH.

More... »

U.K. genomics projects granted $505M

Friday, August 1, 2014 01:41 PM

Genomics England’s 100,000 Genomes Project has received a package of investment worth more than $505 million. The four year project focuses on new research to decode 100,000 human genomes—a patient’s personal DNA code.

More... »


CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs